Detalles de la búsqueda
1.
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer.
BMC Cancer
; 22(1): 394, 2022 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35413826
2.
Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era.
Br J Cancer
; 124(2): 399-406, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33046804
3.
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group.
Lancet
; 385(9980): 1843-52, 2015 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25862517
4.
Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG).
BMC Cancer
; 15: 365, 2015 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25943574
5.
The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer--a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG).
BMC Cancer
; 14: 741, 2014 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25277170
6.
Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands.
Acta Oncol
; 52(5): 950-5, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23517248
7.
Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer.
Clin Colorectal Cancer
; 22(1): 67-75, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36564280
8.
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.
N Engl J Med
; 360(6): 563-72, 2009 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-19196673
9.
Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.
Acta Oncol
; 51(1): 57-64, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22122695
10.
Long-Term Safety Data on S-1 Administered After Previous Intolerance to Capecitabine-Containing Systemic Treatment for Metastatic Colorectal Cancer.
Clin Colorectal Cancer
; 21(3): 229-235, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35341693
11.
Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature.
Ann Surg Oncol
; 18(12): 3252-60, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21822557
12.
Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial.
JAMA Surg
; 156(12): 1093-1101, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34613339
13.
Endothelium-Derived Extracellular Vesicles Associate with Poor Prognosis in Metastatic Colorectal Cancer.
Cells
; 9(12)2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33333805
14.
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.
Lancet
; 370(9582): 135-142, 2007 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-17630036
15.
Current questions in the treatment of advanced colorectal cancer: the CAIRO studies of the Dutch Colorectal Cancer Group.
Clin Colorectal Cancer
; 7(2): 105-9, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18501069
16.
Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab.
PLoS One
; 13(12): e0208080, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30557370
17.
18.
Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group.
Eur J Cancer
; 76: 93-99, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28286287
19.
Bevacizumab and cancer treatment-related mortality.
JAMA
; 305(22): 2292; author reply 2292-3, 2011 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-21642679
20.
Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group.
Clin Colorectal Cancer
; 18(2): e229-e230, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30782413